Welcome to our dedicated page for Marsh & Mclennan news (Ticker: MMC), a resource for investors and traders seeking the latest updates and insights on Marsh & Mclennan stock.
Marsh & McLennan Companies, Inc. reports developments across risk, reinsurance and capital advisory, people and investment consulting, and management consulting. Company updates often center on Marsh Risk and its digital risk analytics tools, Mercer workforce, compensation, health and retirement advisory alliances, Oliver Wyman consulting operations, and Marsh McLennan Agency insurance, benefits, retirement and wealth solutions in the U.S. and Canada.
Recurring news also covers quarterly operating results, enterprise partnerships, AI-enabled service delivery, leadership and governance changes, material agreements, and capital-structure matters tied to the company's common stock and debt financing.
Summary not available.
Summary not available.
Marsh McLennan (NYSE: MMC) reported strong third quarter 2021 results, with GAAP revenue rising 16% to $4.6 billion and underlying revenue up 13%. Operating income surged 37% to $740 million, while adjusted EPS increased 32% to $1.08. For the first nine months of 2021, consolidated revenue was $14.7 billion, marking a 15% increase. The Risk & Insurance Services segment generated $2.7 billion in revenue (+17%) and Consulting reached $1.9 billion (+13%). The company repurchased 1.9 million shares for $300 million in Q3.
Summary not available.
Marsh McLennan (NYSE: MMC) announced the launch of its Cyber Risk Analytics Center, aimed at consolidating cyber risk data and analytics across its divisions: Marsh, Guy Carpenter, Mercer, and Oliver Wyman. This center will provide clients with insights into their cyber threats and risk management strategies. With the increasing prevalence of cyberattacks leading to significant financial losses, the center is designed to enhance clients' resilience to cyber risks. Managing Director Scott Stransky will lead the initiative, supported by collaboration with academic and governmental partners.
Summary not available.
Huron (NASDAQ: HURN) has signed an agreement to divest its Life Sciences Business to Oliver Wyman, a unit of Marsh McLennan (NYSE: MMC). This strategic move is aimed at enhancing Huron's focus on organic revenue growth and margin expansion. The Life Sciences Business contributed approximately 2% of Huron's total revenue for the nine months ended September 30, 2021. The transaction is anticipated to close in November 2021 and is projected to have minimal impact on Huron's full-year 2021 financial guidance. The company plans to use the proceeds to reduce debt and pursue strategic acquisitions.
Summary not available.
Summary not available.
Marsh McLennan (NYSE: MMC) will announce its third quarter financial results on October 21, 2021, before market opening. Following the announcement, President and CEO Dan Glaser and CFO Mark McGivney will host a teleconference at 8:30 a.m. EDT. Investors can participate by dialing 1 866-437-7574 or +1 409-220-9376 for international calls, using access code 4336169. Marsh McLennan, with over $18 billion in annual revenue, provides services in risk, strategy, and people to clients in 130 countries.